Endophyte-Derived Natural Products Using In silico and In vitro Methods for Drug Lead Discovery-A Review
Surendra Jugguru1★, Raju Chatakondu1, Shobha Singarapalle1, Praveena Thirunalveli1★ Corresponding author
- 1Pharmaceutical Chemistry Division, Jagan’s Institute of Pharmaceutical Sciences, Nellore, Andhra Pradesh, INDIA.
CORRESPONDENCE
Surendra Jugguru
Pharmaceutical Chemistry Division, Jagan’s Institute of Pharmaceutical Sciences, Nellore, Andhra Pradesh, INDIA.
Received: 28-11-2025; Revised: 19-12-2025; Accepted: 06-02-2026.
Volume 20, Issue 39 · pp. 34–40 · PUBLISHED · DOI: 10.5530/phrev.20260023
ABSTRACT
Numerous fungal endophytes produce plant-derived chemicals that are pharmacologically useful, making them well-known sources of naturally occurring, biologically active compounds. Alkaloids, coumarins, flavonoids, glycosides, lignans, phenylpropanoids, quinones, saponins, terpenoids, and xanthones, all produced by endophytic fungi, are common plant-derived therapeutic chemicals included in this study. This overview covers research from the initial discovery of Taxol production by endophytic Taxomyces andreanae in 1993 to mid-2020. The study also discusses the challenges to commercializing this innovative approach in drug development, while emphasizing the significant potential for endophyte-based production of such pharmacologically active chemicals derived from plants. This potential offers an optimistic outlook for future drug development. Thanks to recent advances in the "omics" and "one strain many compounds" (OSMAC) methodologies, fungal endophytes have become powerful alternatives to traditional methods.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Jugguru, S., Chatakondu, R., Singarapalle, S., & Thirunalveli, P. (). Endophyte-Derived Natural Products Using In silico and In vitro Methods for Drug Lead Discovery-A Review. Pharmacognosy Reviews, 20(39), 34–40. https://doi.org/10.5530/phrev.20260023